Jordyn Feingold

Jun 5, 2020 | Trainee Corner

Jordyn Feingold, a student in the PORTAL program (MD/MSCR), is currently pursuing her Scholarly Year of Research, funded by our ConduITS CTSA TL1. A graduate of the University of Pennsylvania she holds a Masters in positive Psychology and is deeply committed to investigating the potential clinical impact of the principles in health and disease as evidenced by recent scholarly review on the role of cognitive behavioral therapy and positive psychology for for digestive disorders (J Clin Gastroenterol 2019; 53: 477-485).

Under the mentorship of Laurie Keefer, PhD, her project entitled “Empowered Transitions: Understanding the Experience of Transitioning from Pediatric to Adult GI Care in Adolescents with IBD and Their Parents Using Photovoice” uses mixed methods research to better discern the barriers and facilitators of successful transitions of care for adolescents with IBD and their parents.

To best capture her project, Jordyn developed an infographic that reflects the conceptual framework and provides inspiration for her project. Inflammatory bowel diseases (IBDs) that include Crohn’s disease and ulcerative colitis, are chronic intestinal disorders most often diagnosed in adolescence and young adulthood. Adolescents with IBD are vulnerable to poorer outcomes and higher health costs, partially attributed to disruptions in the continuity of care in the shift from pediatric to adult care settings. Disruptions in care may be due to subtle differences in the paradigms of pediatric verses adult IBD care, poor adolescent self-management skills, non-adherence to medications, low attendance in ambulatory care clinics, and other factors. Additionally, there is presently no universal consensus among providers about the timing of initiation and completion of the transition process for adolescents and young adults with IBD, and access to structured pediatric transition readiness programs are lacking, with a paucity of research to evaluate relevant clinical outcomes in such existing programs. The impact of this study should provide keen insights into behavioral approaches for this clinically relevant unmet need and serve ultimately facilitate better outcomes for this unique and vulnerable population.

Recent ConduITS News

What is the Mount Sinai Exposomics Core?

The Mount Sinai Exposomics Core centers around The Institute for Exposomic Research at the Icahn School of Medicine at Mount Sinai, which was established in 2017 under the leadership of Robert O. Wright, MD, MPH and Rosalind J. Wright, MD, MPH, international leaders...

read more

What does the Exposomics Core do?

The Exposomics Core is at the cutting edge of research to quantify the exposome (i.e., nutrition, social risk factors, and chemical exposure) via lab assays, geospatial modeling, data mining and artificial intelligence. We disseminate our work to cultivate the public...

read more

Highlighted Exposomics Core Events

In 2025, the Exposomics Core was a part of multiple events, including: Lunchtime Chat Webinars (held throughout the year) On January 8, 2025, Maayan Yitshak-Sade, PhD, MPH (Associate Professor, Department of Environmental Medicine, Icahn School of Medicine at Mount...

read more

Exposomics Core Highlighted Information

More information on faculty and staff updates can be found in the departmental newsletters, which are sent out throughout the year. Below are the most recent editions from 2025: December 2025 July 2025 April 2025 The Institute for Exposomic Research is also on...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Dr. Lee 2025 KL2 Scholar

Dr. Lee 2025 KL2 Scholar

Dr. Lee is an Assistant Professor in the Division of Surgical Oncology. Her proposal is titled ‘Generating a Multimodal Machine Learning Model for Prediction of Thyroid Cancer Recurrence’. Her mentors will be: Girish Nadkarni, MD, MPH, Michael Marin, MD, and Gerald...

read more
Dr. Xiaoqi 2025 KL2 Scholar

Dr. Xiaoqi 2025 KL2 Scholar

Dr. Xiaoqi is an Assistant Professor in the Department of Immunology and Immunotherapy. His proposal is titled ‘Nanoparticle STING Immunotherapy Against TP53-Mutated Acute Myeloid Leukemia’. His mentors will be: Brian Brown, PhD, and Joshua Brody, MD.  Dr. Xiaoqi is...

read more